About us Contacts Drug interactions: 390 212
Drug search by name

Equetro and Noxafil (Posaconazole Delayed-Release Tablets)

Determining the interaction of Equetro and Noxafil (Posaconazole Delayed-Release Tablets) and the possibility of their joint administration.

Check result:
Equetro <> Noxafil (Posaconazole Delayed-Release Tablets)
Relevance: 23.07.2022 Reviewer: Shkutko P.M., M.D., in

In the database of official manuals used in the service creation an interaction registered by statistical results of studies was found, which can either lead to negative consequences for the patient health or strengthen a mutual positive effect. A doctor should be consulted to address the issue of joint drug administration.

Consumer:

Ask your doctor before using carBAMazepine together with posaconazole. Using these medications together may decrease the effects of posaconazole. Contact your doctor if your condition or infection worsens. If carBAMazepine is used, carBAMazepine levels should also be monitored closely following starting or stopping of posaconazole, and the carBAMazepine dosage adjusted as necessary. It is important to tell your doctor about all other medications you use, including vitamins and herbs. Do not stop using any medications without first talking to your doctor.

Professional:

GENERALLY AVOID: Phenytoin and other enzyme-inducing anticonvulsants may decrease the plasma concentration of posaconazole. The mechanism is induction of posaconazole clearance via the UDP-glucuronosyltransferase glucuronidation and P-glycoprotein efflux pathways. According to product labeling, coadministration of posaconazole (200 mg tablets once a day) with phenytoin (200 mg once a day) for 10 days resulted in reduced posaconazole mean peak plasma concentration (Cmax) by 41% and systemic exposure (AUC) by 50%. Treatment failure could result. Conversely, posaconazole is an inhibitor of CYP450 3A4 and can increase the plasma levels of phenytoin, which is thought to be partially metabolized by the isoenzyme. Phenytoin Cmax and AUC increased by 16% during coadministration of posaconazole.

MANAGEMENT: Use of posaconazole in combination with enzyme-inducing anticonvulsants should generally be avoided unless the potential benefit outweighs the risk. If coadministration is necessary, patient response to the antifungal agent must be closely monitored. If phenytoin is used, pharmacologic response and serum phenytoin levels should also be monitored closely following initiation or discontinuation of posaconazole, and the phenytoin dosage adjusted as necessary.

References
  • "Product Information. Noxafil (posaconazole)." Schering-Plough Corporation, Kenilworth, NJ.
  • Cerner Multum, Inc. "UK Summary of Product Characteristics." O 0
Equetro

Generic Name: carbamazepine

Brand name: Carbatrol, Epitol, Equetro, Tegretol, Tegretol XR, Tegretol, Tegretol XR

Synonyms: n.a.

Noxafil (Posaconazole Delayed-Release Tablets)

Generic Name: posaconazole

Brand name: Noxafil

Synonyms: Noxafil

In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.